According to reports from Business Standard, Integrated Proteins delivered mixed results for the quarter ended March 2026. The company's standalone net profit increased 9.52% to ₹0.23 crore compared to ₹0.21 crore in the corresponding quarter of the previous year. However, this growth came against a challenging backdrop of significant revenue decline.
As reported by Business Standard, the company experienced a substantial 73.52% decline in sales to ₹5.69 crore in Q4 FY26, down from ₹21.49 crore in Q4 FY25. This dramatic revenue contraction highlights the challenging operating environment faced by the company during the quarter.
According to the financial data reported by Business Standard, Integrated Proteins net profit declined 8.00% to ₹0.23 crore for the full year ended March 2026, compared to ₹0.25 crore in the previous year. The company's annual sales fell 53.77% to ₹9.94 crore from ₹21.50 crore in the corresponding period of the previous financial year.
As reported by Business Standard, the company's operating profit margin (OPM) improved to 3.87% in Q4 FY26 from 2.82% in the previous year quarter. For the full year, the OPM stood at 0.42% compared to 0.42% in the previous year, indicating stable operational efficiency despite the challenging revenue environment.
